However, pretreatment of these tumor cells with the inhibitors SP600125 (for JNK) and ADPC (for NF-κB) did not alter the Poly-G3-mediated reversal of T-cell senescence induced by tumor cells. This evidence concerns the gene MAPK8 and neoplasm.